BioAdaptives Inc (OTCMKTS:BDPT) Stock Gains Momentum: Jumps 9%

As the trading week comes to a close, it is perhaps time for investors to take a look at some of the stocks which managed to make big moves and one of those is the BioAdaptives Inc (OTCMKTS:BDPT) stock.

Market Stats

On Thursday, BDPT stock moved up 9.10% to $0.0060 with more than 80K shares, compared to its average volume of 1.71 million shares. The stock moved within a range of $0.0058 – 0.0061 after opening trading at $0.0058.

BioAdaptives Announces Initial Investigation Results Pluripain® Improves Symptoms of Gadolinium Deposition Disease

The company was in considerable focus among investors yesterday and managed to clock gains of as much as 9% for the day following a key development. BioAdaptives announced the positive results from the study that had been conducted by Lorrin Koran, a professor at the Stanford Medical School, with regards to the product Pluripain.

In the particular study, it was studied if the product could manage the symptoms of Gadolinium Deposition Disease or GDD. The study revealed that as much as 60% of the patients had reported significant reduction in pain after having been administered the medicine.

In addition to pain, brain fog had also been reduced. It goes without saying that it was a major new development for the company and marked a major milestone. Hence, it was perhaps no surprise that investors piled on to the stock in a big way yesterday. It remains to be seen if the stock continues to add to its gains today or not.

Traders Corner

BDPT stock is trading below the 20-Day and 50-Day Moving averages of $0.0067 and $0.0087 respectively.below, the stock is trading below the 200-Day moving average of $0.0236.